Little empirical information is established about synthetic marijuana, including the treatment of related disorders. Similar to organic marijuana, chronic synthetic use can lead to a variety of functional impairments, including diminished academic and workplace productivity and performance. Many traditional approaches emphasize treating co-occurring disorders separately, but the present case examines concurrent treatment for Diagnostic and Statistical Manual of Mental Disorders (4th ed., DSM-IV) Synthetic Marijuana Dependence and Generalized Anxiety Disorder by using Motivational Interviewing (MI) and Relapse Prevention (RP) in conjunction with an adapted form of Dialectical Behavior Therapy (DBT). A model for treatment and its potential effects are discussed.
AdamsonS. J.SellmanJ. (2003). A prototype screening instrument for cannabis use disorder: The Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug and Alcohol Review, 22, 309-315. doi:10.1080/0959523031000154454
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
4.
BaborT. F. (2004). Brief treatments for cannabis dependence: Findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72, 455-466.
5.
BaborT. F.delaFuenteJ. R.SaundersJ.GrantM. (1992). AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for use in primary health care. Geneva, Switzerland: World Health Organization.
6.
BeckA. T.SteerR. A. (1993). Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation.
7.
BeckA. T.SteerR. A.BrownG. K. (1996). Manual for the Beck Depression Inventory–II. San Antonio, TX: Psychological Corporation.
8.
BurkeB. L.ArkowitzH.MencholaM. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71, 843-860.
9.
DimeffL. A.LinehanM. M. (2008). Dialectical behavior therapy for substance abusers. Addiction Science & Clinical Practice, 4, 39-47.
10.
EarleywineM. (2002). Understanding marijuana: A new look at the scientific evidence. Oxford, UK: Oxford University Press.
11.
FergusonK.SgambatiR. E. (2009). Relaxation. In O’DonohueT. W.FisherJ. E. (Eds.), General principles and empirically supported techniques of cognitive behavior therapy (pp. 532-542). Hoboken, NJ: John Wiley.
12.
FirstM. B.SpitzerR. L.GibbonM.WilliamsJ. B. W. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
13.
HurstD.LoefflerG.McLayR. (2011). Psychosis associated with synthetic cannabinoid agonists: A case series: Comment. American Journal of Psychiatry, 168, 1119. doi:10.1176/appi.ajp.2011.11010176
14.
LarimerM. E.PalmerR. S.MarlattG. (1999). Relapse prevention: An overview of Marlatt’s cognitive-behavioral model. Alcohol Research & Health, 23, 151-160.
15.
LinehanM. M. (1987). Dialectical behavior therapy for borderline personality disorder: Theory and method. Bulletin of the Menninger Clinic, 51, 261-276.
16.
LinehanM. M.ComtoisK. A.MurrayA. M.BrownM. Z.GallopR. J.HeardH. L.. . .LindenboimN. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757-766.
17.
MarlattG. A.GordonJ. R. (1985). Relapse prevention: Maintenance strategies in addictive behavior change. New York, NY: Guilford.
18.
MeierM. H.CaspiA.AmblerA.HarringtonH.HoutsR.KeefeR. S.. . .MoffittT. E. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America, 109, E2657-E2664.
19.
MillerW. R. (1983). Motivational interviewing with problem drinkers. Behavioural Psychotherapy, 11, 147-172.
20.
MillerW. R.YahneC. E.ToniganJ. S. (2003). Motivational interviewing in drug abuse services: A randomized trial. Journal of Consulting and Clinical Psychology, 71, 754-763.
21.
MooreB. A.BudneyA. J. (2003). Relapse in outpatient treatment for marijuana dependence. Journal of Substance Abuse Treatment, 25, 85-89.
22.
MoreyL. C. (1991). Personality Assessment Inventory professional manual. Odessa, FL: Psychological Assessment Resources.
23.
MüllerH.SperlingW.KöhrmannM.HuttnerH. B.KornhuberJ.MalerJ. (2010). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309-310. doi:10.1016/j.schres.2009.12.001
24.
OsbornC. J. (2011). Bilingual therapeutics: Integrating the complementary perspectives and practices of motivational interviewing and dialectical behavior therapy. Journal of Contemporary Psychotherapy, 41, 81-90. doi:10.1007/s10879-010-9162-0
25.
ProchaskaJ. O.DiClementeC. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395.
RosenbaumC. D.CarreiroS. P.BabuK. M. (2012). Here today, gone tomorrow . . . and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology, 8, 15-32.
28.
RotgersF.KernM. F.HoeltzelR. (2002). Responsible drinking: a moderation management approach for problem drinkers. Oakland, CA: New Harbinger Publications.
29.
SaladinM. E.AnaE. (2004). Controlled drinking: More than just a controversy. Current Opinion in Psychiatry, 17, 175-187. doi:10.1097/00001504-200405000-00005
30.
SchreinerA. M.DunnM. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20, 420-429. doi:10.1037/a0029117
31.
StephensR. S.RoffmanR. A.CurtinL. (2000). Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898-908.
32.
Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings (NSDUH Series H-41, HHS Publication No. (SMA) 11-4658). Rockville, MD: Author.
33.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2011). Treatment Episode Data Set (TEDS): 2000–2010. National Admissions to Substance Abuse Treatment Services (DASIS Series S-61, HHS Publication No. (SMA) 12-4701). Rockville, MD: Substance Abuse and Mental Health Services Administration.
34.
TofighiB.LeeJ. D. (2012). Internet highs—Seizures after consumption of synthetic cannabinoids purchased online. Journal of Addiction Medicine, 6, 240-241. doi:10.1097/ADM.0b013e3182619004
35.
WuL.GersingK. R.SwartzM. S.BurchettB.LiT.BlazerD. G. (2013). Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. Journal of Psychiatric Research, 47, 555-563. doi:10.1016/j.jpsychires.2012.12.009
36.
ZaleskyA.SolowijN.YücelM.LubmanD. I.TakagiM.HardingI. H.. . .SealM. (2012). Effect of long-term cannabis use on axonal fibre connectivity. Brain, 135, 2245-2255.
